Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration Dec 16, 2008
Source: Generex Biotechnology Corp. ... Dec. 16, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) () and Pevion Biotech Ltd. () have signed an agreement to work together to develop next-generation vaccines and immunotherapeutic products ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Update On Novel Immunotherapeutic Vaccine to be Presented At San Antonio Breast Cancer Symposium Dec 11, 2008
Source: Generex Biotechnology Corp. ... Dec. 11, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) () announced today that further results from its clinical trial of a novel immunotherapeutic cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc., will be presented at the 31st annual San Antonio Breast Cancer Symposium (, December 11-14) ... About Generex Biotechnology Corporation. (Primezone Releases)
Insulin spray for diabetes patients Nov 20, 2008
This buccal insulin spray is developed by Shreya Life Science Pvt Ltd's US collaborator Generex Biotechnology ... For developing Oral-Recosulin, Generex Biotechnology has taken 12 years and spent $240 million. (India Times, India)
Shreya group eyeing over Rs 500 cr turnover in FY09 Nov 14, 2008
This year, we are eyeing a revenue of above Rs 500 crore," Shreya Life Sciences' Chairman and Managing Director Sujit Kumar Singh told reporters here. Shreya Life Sciences is the Indian arm of the Russia-based group. The company, in association with USA/Canada-based Generex Biotechnology Corporation, recently announced that it would launch a human insulin buccal spray under the brand name 'Oral Recosulin'. "Oral Recosulin provides freedom from limitations of conventional insulin therapy or... (Business Standard)
Photo Release -- Generex Launches Oral Insulin for Diabetes Management in India; Retail Availability Coincides With World Diabetes Day Nov 14, 2008
Source: Generex Biotechnology Corp. ... and MUMBAI, India, Nov. 14, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology to Make Convertible Debenture Payment in Cash Nov 12, 2008
Source: Generex Biotechnology Corp. ... Nov. 12, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) () announced today that it intends to make the next payment, due on December 1, 2008, under its Senior Secured Convertible Notes in cash ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Corporation's Antigen Express Subsidiary Featured in Technology Update and Value Focus Review Issued by Scimitar Equity, LLC Nov 10, 2008
Source: Generex Biotechnology Corp. ... BOSTON, Nov. 10, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology (NasdaqCM: - ) announces that Scimitar Equity, LLC issues a review of Generex Biotechnology Corporation, entitled, ``Breaking-out the Sum of the Parts: Antigen Express' Novel Cancer Immunotherapy Emerges as a Jewel ... Investors in Generex Biotechnology (NasdaqCM: - ) now have two (2) product pipelines from which increased value could be realized. (Primezone Releases)
Generex Oral-lyn Featured at International Diabetes Conference Nov 4, 2008
Source: Generex Biotechnology Corp. ... Nov. 4, 2008 (GLOBE NEWSWIRE) -- Generex Oral-lyn(tm) from Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, was featured this week at the 2nd IDF Regional MENA Diabetes Conference and 17th Annual Meeting of the Syrian Diabetes Association ... In his explanation of new delivery methods for insulin, Saleh discusses Generex Biotechnology and its Generex Oral-lyn(tm)... (Primezone Releases)
Generex Biotechnology Awarded New Drug Delivery Patent Oct 27, 2008
Source: Generex Biotechnology Corp. ... Oct. 27, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has received a new patent in Australia ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology to Present At 2008 BioNetwork Conference Oct 7, 2008
Source: Generex Biotechnology Corp. ... Oct. 7, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that William Abajian, Senior Advisor, Global Strategic Alliances & Business Development, will present at the 2008 BioNetwork Conference from October 6-8th at The Ritz Carlton, Laguna Niguel, California ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology to Present Abstracts at Scientific Symposium Sep 5, 2008
Source: Generex Biotechnology Corp. ... Sept. 5, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will present study results at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD, ) to be held in Rome, Italy, September 6 - 11, 2008 () ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology to Sponsor International Diabetes Symposium in Rome Sep 4, 2008
Source: Generex Biotechnology Corp. ... Sept. 4, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will sponsor an international diabetes symposium in Rome, Italy as an adjunct to the 44th Annual Meeting of the European Association for the Study of Diabetes taking place in Rome from September 6-11, 2008 ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Signs Oral Insulin Distribution Deal for Korea Aug 25, 2008
Source: Generex Biotechnology Corp. ... Aug. 25, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has entered into a product licensing and distribution agreement with Dong-Sung Pharm Co. Ltd. () for the importation, marketing, distribution and sale of Generex Oral-lyn(tm), the Company's proprietary oral insulin spray product, in South Korea ... About Generex Biotechnology... (Primezone Releases)
Generex Biotechnology Inks Glucose RapidSpray Distribution Deal in Brazil Aug 21, 2008
Source: Generex Biotechnology Corp. ... Aug. 21, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has entered into a product licensing and distribution agreement with ABP-Comercio, Importacao E Exportacao Ltda ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Comments On Recent Trading Activity Aug 8, 2008
Source: Generex Biotechnology Corp. ... WORCESTER, N.Y., Aug. 8, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, commented today on recent trading activity in its common stock ... About Generex Biotechnology Corporation. (Primezone Releases)
Enrollment of Breast and Ovarian Cancer Patients Commenced for Combination Therapy Trial to Include Generex Biotechnology's Novel Immunotherapeutic Vaccine Aug 7, 2008
Source: Generex Biotechnology Corp. ... Aug. 7, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology announced today that enrollment of patients had begun for a new Phase I clinical trial employing a novel immunotherapeutic cancer vaccine being developed at Antigen Express, its wholly-owned subsidiary ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology to Commence Generex Oral-lyn Trial Involving Subjects With Impaired Glucose Tolerance Aug 5, 2008
Source: Generex Biotechnology Corp. ... Aug. 5, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has received approval from the ethics committee at University Campus Bio-Medico of Rome to conduct a Generex Oral-lyn trial with subjects diagnosed with or susceptible to developing Impaired Glucose Tolerance (IGT) ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Granted Additional Time to Comply With NASDAQ Listing Requirement Jul 26, 2008
Source: Generex Biotechnology Corp. ... July 25, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has been notified by The Nasdaq Stock Market that the bid price of its common stock had closed below $1 ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Featured on FOXNews.com Jul 24, 2008
Generex Biotechnology Featured on FOXNews ... Source: Generex Biotechnology Corporation ... Generex Biotechnology Featured on FOXNews. (Yahoo! Wire -- Entertainment News)
Generex Biotechnology Sponsors Generex Oral-lyn Education & Training Symposium in Middle East Jul 17, 2008
Generex Biotechnology Sponsors Generex Oral-lyn Education & Training Symposium in Middle East: Financial News - Yahoo ... Source: Generex Biotechnology Corp. ... Generex Biotechnology Sponsors Generex Oral-lyn Education & Training Symposium in Middle EastThursday July 17, 9:30 am ET. (Primezone Releases)
Generex Biotechnology Generates New Sales of Approximately $300,000 Through the Generex MENA Office Located in Dubai Healthcare City Center Jul 16, 2008
Source: Generex Biotechnology Corp. ... July 16, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, received a purchase order for the approximate amount of $300,000 through its Generex MENA office from a distributor in Saudi Arabia ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Provides Update On Dosing of Patients in Phase III Trial of Generex Oral-lyn Jul 8, 2008
Source: Generex Biotechnology Corp. ... July 8, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has initiated dosing of over one hundred patients in the Company's pivotal Phase III clinical trial of Generex Oral-lyn(tm), its flagship proprietary oral insulin spray product ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies Jun 26, 2008
Source: Generex Biotechnology Corp. ... June 26, 2008 (PRIME NEWSWIRE) -- Antigen Express, Inc. (), the wholly-owned immunotherapeutics subsidiary of Generex Biotechnology Corporation (NasdaqCM: - ) (), has signed a second collaboration agreement with the Mayo Clinic () ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Presented Data At The Endocrine Society's Annual Meeting Jun 19, 2008
Source: Generex Biotechnology Corp. ... June 19, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, made a podium presentation of data from a company-sponsored study at The Endocrine Society's 90th Annual Meeting (ENDO, ) in San Francisco on June 18, 2008 ... About Generex Biotechnology Corporation. (Primezone Releases)
Generex Biotechnology Presented Data At American Diabetes Association Scientific Sessions Jun 9, 2008
Source: Generex Biotechnology Corp. ... June 9, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, made two podium presentations of data from Company-sponsored studies at the 68th Annual Scientific Sessions of the American Diabetes Association (ADA, ) in San Francisco on June 7, 2008 ... About Generex Biotechnology Corporation. (Primezone Releases)
Gum may be used to help type-2 diabetes May 18, 2008
The side-effects were especially off-putting to the increasing number of children diagnosed with type-2, according to the Generex Biotechnology Corporation of Toronto, Canada ... Generex Biotechnology's flagship product is an oral insulin taken through the inner lining of the mouth instead of by injection. (Sydney Morning Herald -- Australia)
Generex Biotechnology Receives Another Regulatory Approval to Conduct Phase III Clinical Trial for Generex Oral-lyn for One of the Largest Global Locations Selected by the Company Feb 14, 2008
Source: Generex Biotechnology Corp. ... Feb. 14, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that on January 10, 2008 the Company received an additional regulatory approval letter for the conduct of its Phase III clinical trial protocol for Generex Oral-lyn(tm) at an additional 28 clinical sites located in Europe ... Source: Generex Biotechnology Corp.. (Primezone Releases)
Generex Biotechnology Announces Participation At 2008 Arab Health Congress Together With Middle Eastern Marketing and Distribution Partner Jan 15, 2008
Source: Generex Biotechnology Corp. ... Jan. 15, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will be participating at the upcoming 2008 Arab Health Congress () ... Source: Generex Biotechnology Corp.. (Primezone Releases)
Generex Biotechnology Awarded Patent in Japan For Its Antigen Presentation Technology Dec 18, 2007
Source: Generex Biotechnology Corp. ... Dec. 18, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) announced today that its wholly owned subsidiary, Antigen Express, Inc., has been awarded a Japanese patent strengthening its proprietary antigen presentation technology platform ... Source: Generex Biotechnology Corp.. (Primezone Releases)
First Prostate Cancer Patients Treated in a Phase I Clinical Trial as Part of a Collaboration Between Generex Biotechnology and the Saint Savas Cancer Hospital Nov 5, 2007
Source: Generex Biotechnology Corp. ... Nov. 5, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) announced today that the first prostate cancer patients had been treated with its novel peptide vaccine in a Phase I clinical trial ... Source: Generex Biotechnology Corp.. (Primezone Releases)
Pharma majors eye diabetes market in India Nov 3, 2007
New Delhi, Nov 2 Even as pharma major Pfizer recently withdrew its inhaled product for diabetes, India with huge diabetes population seems to attract such as Novo Nordisk, Generex Biotechnology Corporation and Elly Lilly ... Denmark-based Novo Nordisk is through with phase III clinical trials at several locations across the globe and is planning to introduce 'Aerx' soon, while the US-based Generex Biotechnology Corp has announced a partnership with Shreya Lifesciences to launch Oral-lyn by March... (Financial Express)
Generex Biotechnology Awarded United States Patent Oct 2, 2007
Source: Generex Biotechnology Corp. ... Oct. 2, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that the United States Patent and Trademark Office has granted the Company a new United States Patent ... Source: Generex Biotechnology Corp.. (Primezone Releases)
Generex Biotechnology to Collaborate With Leading Investigator At the Univerity of Rochester On Pandemic Avian Influenza Vaccine Aug 22, 2007
Source: Generex Biotechnology Corp. ... Aug. 22, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) announced today that its wholly-owned immunotherapy subsidiary, Antigen Express, Inc., has entered into an agreement with the University of Rochester as part of the Antigen Express efforts to develop a novel vaccine against the potentially pandemic avian influenza ... Source: Generex Biotechnology Corp.. (Primezone Releases)
Generex Biotechnology Corporation Announces Prestigious National Award Received by Clinical Investigator Who Has Done Extensive Work On Generex Oral-lyn Jul 24, 2007
Source: Generex Biotechnology Corp. ... July 24, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Dr. Jaime Guevara-Aguirre was recently awarded the Vicente Rocafuerte Award for Scientific Merit ... Generex Biotechnology Corporation Shayne Gilliatt 800-391-6755 or 416-364-2551 CEOcast, Inc. Andrew Hellman 212-732-4300. (Primezone Releases)
Generex Biotechnology to Participate At the Diet, Nutrition & Vitamin Efficient Program Planning Session Jul 17, 2007
Generex Biotechnology to Participate At the Diet, Nutrition & Vitamin Efficient Program Planning Session: Financial News - Yahoo ... Source: Generex Biotechnology Corp. ... Generex Biotechnology to Participate At the Diet, Nutrition & Vitamin Efficient Program Planning SessionTuesday July 17, 9:30 am ET. (Primezone Releases)
Generex Biotechnology Announces New Licensing Agreement for Generex Oral-lyn Jul 10, 2007
Source: Generex Biotechnology Corp. ... July 10, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has entered into an exclusive Product Licensing & Distribution Agreement with the Armenian Development Agency (ADA) () and Canada Armenia Trading House Ltd. (CATH) for the commercialization of Generex Oral-lyn(tm), the Company's proprietary oral insulin spray... (Primezone Releases)
Generex Biotechnology to Make Presentations At the American Diabetes Association's 67th Scientific Sessions Jun 23, 2007
Source: Generex Biotechnology Corp. ... June 22, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will be making three poster presentations at the American Diabetes Association's 67th Scientific Sessions in Chicago, IL June 22-26, 2007 ( and ) ... Source: Generex Biotechnology Corp.. (Primezone Releases)
Money Sunflashes May 31, 2007
TORONTO -- Generex Biotechnology Corp. is on the verge of obtaining government approvals for its Oral-lyn insulin mouth spray in jurisdictions other than Ecuador, the first country that approved the product for use by diabetics, CEO Anna Gluskin says. The firm is hoping for approvals from 13 countries in the Middle East in six to eight months, Canadian acceptance within 18 months, and a U.S. regulatory thumbs-up in 28 months. (Canoe.ca)
US Military Cancer Institute partners on cancer trial Feb 17, 2007
Rockville, MDThe United States Military Cancer Institute (USMCI) and Generex Biotechnology Corporation announced that they have entered into a Phase II clinical trial for a novel peptide vaccine for breast cancer. The immunotherapeutic vaccine, AE37, is being developed by Generex's Antigen Express division in the U.S. The study will be conducted in conjunction with USMCI's Clinical Trials Group. (EurekAlert! -- Business News)
